Trade-secret claims are becoming a popular way to protect intellectual property, and life science companies are on the bandwagon, IP lawyers told Bloomberg Law.
“Intellectual property holders are increasingly aware they have this tool in their arsenal,” Michael W. De Vries, with Kirkland & Ellis LLP in Los Angeles, told Bloomberg Law. De Vries has substantial experience representing clients in complex intellectual property disputes including patent litigation and litigation involving misappropriation of trade secrets.
DUSA Pharmaceuticals, Inc., a subsidiary of Sun Pharmaceutical Industries Ltd.; Par Pharmaceutical, a subsidiary of Endo Pharmaceuticals Inc.; and closely held genetic-sequencing company ArcherDX are just ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.